SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!
rrrrrrry
Lv2
140 积分
2024-03-04 加入
最近求助
最近应助
互助留言
Emerging immunotherapies in multiple myeloma
1小时前
待确认
Daratumumab, lenalidomide, and dexamethasone versus lenalidomide and dexamethasone alone in newly diagnosed multiple myeloma (MAIA): overall survival results from a randomised, open-label, phase 3 trial
14小时前
已完结
Subcutaneous versus intravenous daratumumab in patients with relapsed or refractory multiple myeloma (COLUMBA): a multicentre, open-label, non-inferiority, randomised, phase 3 trial
1天前
已完结
An evaluation of subcutaneous daratumumab for the treatment of multiple myeloma
1天前
已完结
Effect of High-Cutoff Hemodialysis vs Conventional Hemodialysis on Hemodialysis Independence Among Patients With Myeloma Cast Nephropathy: A Randomized Clinical Trial
1天前
已完结
Prognostic impact of 18F-FDG PET/CT in patients with multiple myeloma presenting with renal impairment
1天前
已完结
N-Terminal Fragment of Brain-Type Natriuretic Peptide (NT-proBNP) as a Prognostic Marker in Patients with Newly Diagnosed Multiple Myeloma Complicated by Dialysis-Dependent Renal Failure
1天前
已完结
International Myeloma Working Group Recommendations for the Diagnosis and Management of Myeloma-Related Renal Impairment
1天前
已完结
International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma
1天前
已完结
Management of multiple myeloma-related renal impairment: recommendations from the International Myeloma Working Group
1天前
已完结
没有进行任何应助
我找到了【积分已退回】
1天前
不是这篇,正确的doi: 10.1038/s41572-024-00529-7
1天前
您好,需要的是补充材料,不是正文。但仍感谢帮助
14天前
已找到【积分已退回】
24天前
已找到【积分已退回】
24天前
已找到【积分已退回】
28天前
不是这篇
28天前
感谢
28天前
感谢
28天前
感谢
28天前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论